By using brush-border membrane vesicles (BBMVs) from guinea-pig ileum. we have shown that intestinal CI -transport involves mainly an electroneutral CI-/H+ symport (CI-/OH-antiport). In contrast, these vesicles exhibit only little rheogenic CI-uniport activity and neither CI-/Na', CI-/K+ nor 2Cl-/Na'/K+ symport activities [ I].
By using brush-border membrane vesicles (BBMVs) from guinea-pig ileum. we have shown that intestinal CI -transport involves mainly an electroneutral CI-/H+ symport (CI-/OH-antiport). In contrast, these vesicles exhibit only little rheogenic CI-uniport activity and neither CI-/Na', CI-/K+ nor 2Cl-/Na'/K+ symport activities [ I] .
To distinguish between a specific CI-/OH-antiporter (where the main substrate would indeed be O H -) and a less specific CI-/anion antiporter accepting either C1-or HCO, in the place of OH -, we have re-examined the effect of (cold) fruns-CI-on cis-""CI-uptake. This uptake was quantified under standard conditions (Fig. 1) by using a rapid filtration technique and guinea-pig ileal BBMVs preloaded under iso-osmotic conditions with the appropriate ions by entrapment during vesicle formation.
To short-circuit all possible electrical gradients, the experiments reported here were all performed in the presence of equilibrated K + concentrations and valinomycin. As verified in separate experiments, these conditions offer the additional advantage of permitting the instant abolition of all pH gradients simply by the addition of the K + / H + ionophore. nigericin.
In the absence both of a pH gradient (pH,,,, = pH,, = 7.5 j and of trutis-cl-(Cl~~u,/CI,~ = 14/0 mM), c1-uptake occurs downhill and is unaffected by nigericin (lowest curve, Fig. 1 ).
At the same pH, vesicle prcloading to CIJCI,; = 14/200 mM causcs a 230% increasc in the initial rate of C1-uptake and leads t o a transient CI-accumulation with an overshoot at 20 s (r2 [,j=2 .2 (upper curve, Fig. 1 j. Under these conditions, nigericin inhibits only slightly the initial ratc of chloride uptake, but drastically reduces the size of the overshoot to r2(, = 1.3 (middle curve, Fig. 1 ).
Although these results scem to suggest the existence in the small intestine of a CI -/CI-exchange mechanism, other experimental evidence indicates the absence of any obligatory CI-/CI-antiport sincc C1-uphill transport can be energized by alcalin-inside radients in the total absence of eithcr truris-CI-or HCO Here, wc propose an alternative explanation for thc results in Fig. I , based on a gencral co-transport model in which CIand H' arc two co-substrates, each binding to its own specific binding site in a two-site carrier.
Wc distinguish two phascs in the stimulatory effcct of /rutis-CI-. First, at 2 s (initial entry rate), there is a strong stimulation that is inhibited only slightly by nigericin. This can be interpreted casily in tcrms of carrier theory. If the permeability constant of the cmpty carrier is small when compared with that o f the CI --loaded carrier. cold trutis-Clwould facilitatc carricr recycling and therefore stimulate the initial entry ratc of cis-3"CI .
Secondly, at longer time pcriods. trrrn.s-CI energizes "'CI-uphill transport for two reasons: at the high intravesicular CI ~ concentrations uscd, the carrier would be saturated, and proton efflux through the C1-/H + symport would occur readily and faster than proton influx by the same mechanism. The alcalin-inside pH gradient thus rcsulting would be sufficient to cause the nigericin-sensitive CI ~ overshoot observed. The small, time-dependent, nigcricininsensitive component of the overshoot, evidcnccd by the middle curve in Fig. 1 , can be explained in terms of cold intravesicular C1-inhibiting competitively the efflux of intravesicularly trapped 3"CI -.
In conclusion, we point out that if. from a physicochcmical point of view, a CIV/H+ symport and a CI-/OH-antiport are equivalent, and therefore indistinguishable. a quantitativc analysis of the co-transport model proposed here might permit a two-site CI-/H+ symport and a singlc-site Cl-/ OH-antiport to be distinguishcd kinetically.
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